Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Clinical Pharmacology|January 1, 1991
Plasma adenosine concentrations during adenosine-induced respiratory stimulation in manP G Reid, A H Watt, W J Penny, et al.
European Journal of Clinical Pharmacology|March 11, 1977
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.
British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
Clinical and Laboratory Haematology|January 1, 1987
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolismA G Fennerty, J Dolben, P Thomas, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.
BMJ (Clinical Research Ed.)|February 10, 2007
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialI A Campbell, D P Bentley, R J Prescott, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Sodium and renin in the hypertension of early renal diseaseS F Wong, M I Mitchell, V Robson, et al.
QJM : Monthly Journal of the Association of Physicians|December 1, 1996
Changing patterns of self-poisoning in a UK health districtM C Bialas, P G Reid, P Beck, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Determinants of free theophylline clearance in asthmaP E Williams, Y A Alwazir, M Littley, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetesH Linnebjerg, P A Kothare, M Seger, et al.
Pageof 13